Cargando…
Drug Abuse
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Nova Science Publishers, Incorporated,
2018.
|
| Colección: | Alcohol and Drug Abuse Ser.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro; Contents; Preface; Chapter 1; Opioid Treatment Programs and Related Federal Regulations(; Summary; Medication-Assisted Treatment (MAT); Methadone; Buprenorphine; Naltrexone; Regulatory Framework; Federal Food, Drug, and Cosmetic Act (FFDCA); Controlled Substances Act (CSA); Opioid Treatment Programs (OTPs); OTP Accreditation; OTP Certification; OTP Registration; DATA-Waived Providers (DWPs); Practitioner Requirements; Medication Requirements; Chapter 2; Increase in Illicit Fentanyl Overdose Deaths*; Summary; What Is Fentanyl?; Rise of Fentanyl Overdoses; Availability of Fentanyl
- Policy ConsiderationsChapter 3; The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action(; Summary; FDA Approval of Prescription Drugs and the Challenges of Opioids; FDA Authority and Recent Agency Action Related to the Opioid Epidemic; Decreasing Exposure and Preventing New Addiction; Supporting the Treatment of Those with Opioid Use Disorder; Fostering the Development of Novel Pain Treatment Therapies; Improving Enforcement and Assessing Benefit Risk; Selected Opioid-Related Bills in the 115th Congress That Would Amend the FD & C Act; Chapter 4
- High Intensity Drug Trafficking Areas (HIDTA) Program(Summary; HIDTA Designations; Coordination; Funding; HIDTA Issues for Consideration; Unit of Inclusion; County-Level Drug Trafficking Data; Criteria for Inclusion; Program Effectiveness; Program Scope; Use of Funds for Treatment and Prevention Initiatives; Heroin Response Strategy; HIDTA as an ONDCP Component; Chapter 5; Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis(; Summary; Brief Background on the Opioid Epidemic; Overview of the CSA; Scheduling of Controlled Substances
- Emergency or Temporary SchedulingScheduling in Order to Satisfy International Treaty Obligations; Who Must Register with the DEA?; Exceptions to the Registration Requirement; Regulatory Obligations of Registrants Under the CSA; Recordkeeping; Security Measures; Reporting; Quotas; Prescription Requirements; Practitioners; Pharmacists; What Are the Potential Consequences for Violating the CSA?; State Regulation of Controlled Substances; DEA's Legal Authorities for Enforcing the CSA; Investigations; Enforcement Actions; Letter of Admonition or Informal Hearing
- Administrative Proceedings to Deny, Revoke, or Suspend a RegistrationImmediate Suspension Orders; Responding to the Opioid Abuse Crisis: DEA Actions and Amendments to the CSA; DEA Actions Against Registrants; Emergency Scheduling of Illicit Fentanyl; Expanding Disposal Options for Unwanted Opioid Medication; CARA and Medication-Assisted Treatment for Opioid Addiction; Aggregate Production Quotas for Certain Schedule II Opioids; Selected Opioid-Related Bills in the 115th Congress That Propose Amending the CSA; Chapter 6; Federal Support for Drug Courts: In Brief*; Summary; Introduction